Document is current
Any future updates will be listed below
-
Authors
de Araujo Tavares, Maria Eduarda
Cupertino, Renata Basso
Bandeira, Cibele Edom
da Silva, Bruna Santos
Vitola, Eduardo Schneider
Salgado, Carlos Alberto Iglesias
dos Santos Soares, Robson
Picon, Felipe Almeida
Rohde, Luis Augusto
Rovaris, Diego Luiz
Grevet, Eugenio Horacio
Bau, Claiton Henrique Dotto https://orcid.org/0000-0001-5644-3845
-
Funding
Funding for this research was provided by:
CNPQ (466722/2014-1)
CNPq (424041/2016-2)
FAPERGS (PqG-19/2551-0001731-6, PqG-19/2551-0001668-9)
FAPESP (2020/05652-0)
- License Information
-
More Information
Article History
Received: 27 October 2022
Accepted: 20 March 2023
First Online: 1 April 2023
Declarations
:
: The authors declare the following potential conflict of interest: Dr. Grevet was on the speaker’s bureau for Novartis and Shire for three years and received travel awards (air tickets and hotel accommodations) for participating in two psychiatric meetings from Shire and Novartis. Luis Augusto Rohde has received grant or research support from, served as a consultant to, and served on the speakers’ bureau of Aché, Bial, Medice, Novartis/Sandoz, Pfizer/Upjohn, and Shire/Takeda in the last three years. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by Dr Rohde have received unrestricted educational and research support from the following pharmaceutical companies in the last three years: Novartis/Sandoz and Shire/Takeda. Dr. Rohde has received authorship royalties from Oxford Press and ArtMedAll other authors declare that they have no conflict of interest.
